Very limited published evidence of safety indicates only negligible amounts in breast milk following depot injection. However maternal oral doses of up to 20mg daily produce low levels in milk and undetectable levels in infant’s plasma

Long half-life increases risk of accumulation in breastfed infants

Occasional adverse effects reported including somnolence, lethargy poor sucking, irritability and tremor

Monitor infant for sedation, poor feeding, behavioural effects, extrapyramidal symptoms, and developmental milestones